European Organisation For Research & Treatment Of Cancer
Pazopanib Hydrochloride or a Placebo in Treating Patients With Non-Small Cell Lung Cancer Who Have Received First-Line Chemotherapy
- Conditions
- Lung Cancer
- Interventions
- Other: laboratory biomarker analysisOther: pharmacogenomic studiesOther: pharmacological studyProcedure: quality-of-life assessment
- First Posted Date
- 2010-09-23
- Last Posted Date
- 2018-07-12
- Target Recruit Count
- 102
- Registration Number
- NCT01208064
- Locations
- 🇩🇪
Klinik Loewenstein, Loewenstein, Germany
🇬🇷University General Hospital Heraklion, Heraklion, Greece
🇩🇪UniversitaetsMedizin Mannheim, Mannheim, Germany
Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma
- Conditions
- Sarcoma
- Interventions
- Other: laboratory biomarker analysisProcedure: quality-of-life assessment
- First Posted Date
- 2010-08-26
- Last Posted Date
- 2014-08-08
- Target Recruit Count
- 133
- Registration Number
- NCT01189253
- Locations
- 🇫🇷
ASSISTANCE PUBLIQUE - HôPITAUX DE MARSEILLE - HôPITAL DE LA TIMONE, Marseille, France
🇺🇸Methodist Estabrook Cancer Center, Omaha, Nebraska, United States
🇩🇪Universitaetsklinikum Koeln, Koeln, Germany
Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia
- Conditions
- LymphomaLeukemia
- First Posted Date
- 2010-08-20
- Last Posted Date
- 2017-07-28
- Target Recruit Count
- 1200
- Registration Number
- NCT01185886
- Locations
- 🇵🇹
Instituto Portugues De Oncologia - Centro Do Porto, Porto, Portugal
🇧🇪U.Z. Leuven - Campus Gasthuisberg, Leuven, Belgium
🇧🇪Universitair Ziekenhuis Brussel, Brussels, Belgium
Bevacizumab in Recurrent Grade II and III Glioma
- Conditions
- Central Nervous System Tumors
- Interventions
- Biological: Bevacizumab
- First Posted Date
- 2010-07-16
- Last Posted Date
- 2019-02-28
- Target Recruit Count
- 155
- Registration Number
- NCT01164189
- Locations
- 🇧🇪
U.Z. Leuven - Campus Gasthuisberg, Leuven, Belgium
🇦🇹Medical University Vienna - General Hospital AKH, Vienna, Austria
🇫🇷CHU Pitie-Salpetriere, Paris, France
Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence
- Conditions
- Head and Neck Cancer
Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer
- Conditions
- Adenocarcinoma of the Gastroesophageal JunctionGastric Cancer
- Interventions
- First Posted Date
- 2010-05-14
- Last Posted Date
- 2016-10-12
- Target Recruit Count
- 29
- Registration Number
- NCT01123473
- Locations
- 🇧🇪
Institut Jules Bordet, Brussels, Belgium
🇵🇹I.P.O. Francisco Gentil - Centro De Lisboa, Lisboa, Portugal
🇧🇪U.Z. Gasthuisberg, Leuven, Belgium
Male Breast Cancer: Understanding the Biology for Improved Patient Care
- Conditions
- Breast Cancer
- First Posted Date
- 2010-04-12
- Last Posted Date
- 2023-09-11
- Target Recruit Count
- 200
- Registration Number
- NCT01101425
- Locations
- 🇬🇷
Thermi Clinic, Thessaloniki, Greece
🇬🇧Leighton Hospital, Crewe, United Kingdom
🇬🇧Worthing Hospital, Worthing, West Sussex, United Kingdom
Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer
- Conditions
- Kidney Cancer
- Interventions
- Procedure: timing of surgeryGenetic: gene expression analysisOther: biologic sample preservation procedureOther: laboratory biomarker analysisProcedure: therapeutic conventional surgery
- First Posted Date
- 2010-04-07
- Last Posted Date
- 2017-02-08
- Target Recruit Count
- 99
- Registration Number
- NCT01099423
- Locations
- 🇳🇱
Academisch Ziekenhuis Maastricht, Maastricht, Netherlands
🇳🇱Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
🇧🇪Cliniques Universitaires St. Luc, Brussels, Belgium
Lenalidomide Maintenance Post-debulking in Advanced CTCL
- First Posted Date
- 2010-04-05
- Last Posted Date
- 2018-07-09
- Target Recruit Count
- 21
- Registration Number
- NCT01098656
- Locations
- 🇦🇹
Medical University of Graz, Graz, Austria
🇫🇷Nouvel Hopital Estaing, Clermont-Ferrand, Cedex 1, France
🇫🇷Chu de Bordeaux - Hopital Du Haut Leveque, Bordeaux, Pessac Cedex, France
Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
- Conditions
- Brain and Central Nervous System Tumors
- Interventions
- First Posted Date
- 2009-11-25
- Last Posted Date
- 2018-07-09
- Target Recruit Count
- 111
- Registration Number
- NCT01019434
- Locations
- 🇮🇹
Ospedale Bellaria, Bologna, Italy
🇧🇪UZ Leuven, Leuven, Belgium
🇳🇱Erasmus MC - Daniel den Hoed Cancer Center, Rotterdam, Netherlands